Prime Minister Shri Narendra Modi has conveyed India’s happiness to be the home of WHO Global Centre for Traditional Medicine. He expressed the hope that the center will contribute towards making a healthier planet and leveraging our rich traditional practices for global good.

Ayush Ministry and WHO have signed host country agreement for the center. This Centre will contribute towards making a healthier planet and leveraging our rich traditional practices for global good. Read More

“BRICS R&D Centre will help to pool together complementary advantages of BRICS countries in vaccine research and development and boost the capacity of BRICS countries to prevent and control infectious diseases and provide timely help to other developing countries in need.”

Union Minister of Health and Family Welfare, Dr. Mansukh Mandaviya said as he launched the BRICS Vaccine R&D Center and Workshop on Vaccine Cooperation through video conference. Read More

Dr. Mansukh Mandaviya, delivering the ‘special address’ in an event to celebrate World TB Day 2022, highlighted that a 360-degree holistic approach is the cornerstone of TB elimination in India.

“We are determined and committed to achieve our Hon’ble PM’s vision of eliminating TB by 2025, five years ahead of the target for TB set by SDG 2030. Through the active efforts of all the states and the sustained guidance to the programme by our country’s leadership, the programme has advanced through challenging times,” he said. Read More

Ministry of Ayush is conducting the world's first multicenter Phase - III clinical trial examining the efficacy of Ayurveda in the treatment of Rheumatoid Arthritis.

The clinical trial will be conducted in accordance with stringent International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use – Good Clinical Practice (ICH- GCP) guidelines. Read More

US-based Novavax, Inc. and Serum Institute of India (SII) have announced that the Drugs Controller General of India (DCGI) has granted emergency use authorization (EUA) for Novavax' protein-based COVID-19 vaccine for adolescents aged ≥12 to <18 years in India.

The vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by SII under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India. Read More

WHO’s new Guidelines for the clinical management of severe illness from influenza virus infections provide recommendations on the use of influenza antivirals, adjunctive therapies and diagnostic strategies.  

The new guidelines are intended to guide clinicians in their care of patients with or at risk of severe illness from seasonal, zoonotic or pandemic influenza. The guidelines were developed using a robust method that included commissioning systematic reviews and evaluating the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. Read More

The role of people’s representatives is most important in a democracy, said the President of India, Shri Ram Nath Kovind. He was addressing the members of the Gujarat Legislative Assembly in Gandhinagar on March 24, 2022). For the first time in history, the President has addressed an assembly of the country.

The President said that the members of the Legislative Assembly are representatives of the people of their area and state. But the more important thing is that the people consider them to be the creators of their destiny. Read More

On 23rd March 2022, Gujarat University Startup and Entrepreneurship Council (GUSEC) has organized an assessment of Project proposals by StartUps. An initiative under Dr. Jaimin Vasa MSME Chair @ Gujarat University.

Our Respected Dr. Jaimin Vasa (Chairman - Vasa Pharmachem, President of Gujarat Chemical Association, BoA of Accuprec) chaired the event. 

Our Respected Mr. Padmin Buch (Senior Advisor-Corporate Strategy & IPR, Ex-MD - GITCO, BoA of Accuprec) was invited to the event to assess the Projects.

Accuprec Research Labs Pvt. Ltd. at “Innovations And Developments In Medical Plastics/Devices & Pharma Packaging” Seminar, at Federation of Telangana Chambers of Commerce and Industry, Hyderabad.

Dr. Manish Rachchh, Director & CEO of Accuprec share his expert knowledge on "Regulatory Testing of Medical Grade Plastics & Packaging Material - CDSCO, CE & 510(k) perspective"

Mr. Mayur Kandoriya, Director & CMO & Mr. Jainik Khamar, Research Associate (PT) from Accuprec have attended the seminar.

On 25th March 2022, Accuprec Research Labs Pvt. Ltd. has participated in the 28th Edition of Medicall Expo 2022 @Hyderabad. Medicall, is India’s largest B2B Medical Equipment Exhibition.

Medicall is the largest gathering of healthcare and Trade professionals in India welcoming over 30,000 attendees from 20+ countries. From Accuprec Dr. Manish Rachchh (Director & CEO), Mr. Mayur Kandoriya (Director & CMO) & Mr. Jainik Khamar (Research Associate) has participated in the Medicall Expo 2022.

On 26th March 2022, Gujarat Council On Science & Technology (GUJCOST) Sponsored National Webinar On “Intellectual Property Rights - Encourage, Innovation and Entrepreneurship” organized by the Faculty of Pharmacy - Marwadi University, Rajkot, Gujarat.

Our respected Dr. Manish Rachchh, (Director & CEO of Accuprec) was the expert speaker at the webinar. He shared his expert knowledge on the topic.

On 25th March 2022, Accuprec has organized a Health Checkup Camp for all the staff members of Accuprec.

A team of specialists conducted all the routine tests such as Complete Blood Count (CBC), Blood Pressure, Oxygen level, Eye checkup. Along with the routine tests, the team of specialist also provided the Hepatitis B vaccine. Accuprec annually organizes the Health Checkup Camp for the betterment of employees' health.